PT1064014E - Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus - Google Patents

Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus

Info

Publication number
PT1064014E
PT1064014E PT99916884T PT99916884T PT1064014E PT 1064014 E PT1064014 E PT 1064014E PT 99916884 T PT99916884 T PT 99916884T PT 99916884 T PT99916884 T PT 99916884T PT 1064014 E PT1064014 E PT 1064014E
Authority
PT
Portugal
Prior art keywords
papilomavirus
impediment
medication
tumors
treatment
Prior art date
Application number
PT99916884T
Other languages
English (en)
Inventor
Burger Alexander
Hallek Michael
Original Assignee
Medigene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigene Ag filed Critical Medigene Ag
Publication of PT1064014E publication Critical patent/PT1064014E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT99916884T 1998-03-24 1999-03-24 Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus PT1064014E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19812941A DE19812941A1 (de) 1998-03-24 1998-03-24 Arzneimittel zur Vermeidung oder Behandlung von Papillomavirusspezifischem Tumor

Publications (1)

Publication Number Publication Date
PT1064014E true PT1064014E (pt) 2005-06-30

Family

ID=7862148

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99916884T PT1064014E (pt) 1998-03-24 1999-03-24 Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus

Country Status (12)

Country Link
EP (1) EP1064014B1 (pt)
JP (1) JP2002509863A (pt)
AR (1) AR014768A1 (pt)
AT (1) ATE288279T1 (pt)
AU (1) AU755242B2 (pt)
CA (1) CA2323573A1 (pt)
DE (2) DE19812941A1 (pt)
DK (1) DK1064014T3 (pt)
ES (1) ES2237913T3 (pt)
MX (1) MXPA00009282A (pt)
PT (1) PT1064014E (pt)
WO (1) WO1999048518A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE514982C2 (sv) * 1999-09-30 2001-05-28 Active Biotech Ab Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
DE10059630A1 (de) * 2000-12-01 2002-06-06 Medigene Ag Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor
JP4614765B2 (ja) † 2002-05-17 2011-01-19 ユニバーシティ・オブ・ケープ・タウン Ｌ２ペプチドを含むキメラ・ヒト・パピローマウイルス１６ｌ１タンパク質、それから調製したウイルス様粒子および該粒子の調製方法
JP5186678B2 (ja) * 2005-10-13 2013-04-17 財団法人ヒューマンサイエンス振興財団 経皮抗原投与のための抗原キット

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435907C2 (de) * 1994-10-07 1997-07-24 Lutz Prof Dr Gissmann Papillomavirusähnliche Partikel und deren Anwendung

Also Published As

Publication number Publication date
DK1064014T3 (da) 2005-05-30
AU3521499A (en) 1999-10-18
CA2323573A1 (en) 1999-09-30
DE19812941A1 (de) 1999-10-07
DE59911556D1 (de) 2005-03-10
JP2002509863A (ja) 2002-04-02
ES2237913T3 (es) 2005-08-01
WO1999048518A2 (de) 1999-09-30
EP1064014B1 (de) 2005-02-02
MXPA00009282A (es) 2002-12-13
ATE288279T1 (de) 2005-02-15
EP1064014A2 (de) 2001-01-03
WO1999048518A3 (de) 1999-12-02
AU755242B2 (en) 2002-12-05
AR014768A1 (es) 2001-03-28

Similar Documents

Publication Publication Date Title
BR9508886A (pt) Compostos e métodos para o tratamento de câncer
BR9711530A (pt) Combina-Æo de terapia para tratamento de psicoses
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
NO20003525L (no) Biologisk væskebehandlingssystem
GB9806038D0 (en) Magnetic device for the treatment of fluids
NO20010882L (no) Terapier for behandling av lungesykdommer
DE69922462D1 (de) Wegwerfhöschen
NO991496D0 (no) Kondisjonerende oppl°sninger for behandling av harde kontaktlinser
NO20004688D0 (no) Terapi ved østrogenassosierte lidelser
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
DE69908437T2 (de) Wegwerfhöschen
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
PT752870E (pt) Utilizacao de mycobacterium para o tratamento de tumores
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO20005179D0 (no) Medikament behandling
NO20006047L (no) Fremgangsmåte for genterapi
IT1303677B1 (it) Dispositivo per il trattamento termico di pezzi.
PT853959E (pt) Composicao para o tratamento do amianto
HUP0101947A3 (en) Combination for the treatment of tumors
PT1064014E (pt) Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NL192620B (nl) Putbehandelingsvloeistoffen.
DE50011084D1 (de) Verwendung von azolen zur prävention von strahlen-induziertem hautkrebs
AU1940800A (en) Combination therapy for the treatment of sepsis